Treatment of chronic suppurative otitis media with ofloxacin in hydroxypropyl methylcellulose ear drops: a clinical/bacteriological study in a rural area of Malawi
- PMID: 11879929
- DOI: 10.1016/s0165-5876(01)00648-6
Treatment of chronic suppurative otitis media with ofloxacin in hydroxypropyl methylcellulose ear drops: a clinical/bacteriological study in a rural area of Malawi
Abstract
Chronic suppurative otitis media in young children is a major problem in Africa, with socio-economic consequences at a later age. Common treatment regimens with antibiotics are expensive and often not practically feasible. Therefore, a project was started to develop a low-cost and effective treatment in a rural area of Malawi by studying the clinical efficacy of an inexpensive application regimen of ofloxacin (0.075%) in hydroxypropyl methylcellulose (1.5%) ear drops. In earlier studies with this treatment regimen, it was possible to cure approximately 70% of ears. The aim of this study was to find out whether the bacteriological spectrum cultured from wet ears before and after treatment, and patterns of resistance to antibiotics, played a role in the percentage of cures. Patients with long-standing chronic suppurative otitis media were clinically assessed and treated with suction cleaning and instillation of ear drops on days 1, 3, 7 and 10. Bacterial swabs were taken for culture and sensitivity tests for ofloxacin were on days 1 and 10 from the ears that were still discharging. After 21 weeks, the ears were assessed again clinically. Clinical cure was considered to be complete cessation of otorrhea. Ninety of 104 tested patients (124 ears) completed the study. About 73% of the ears had become dry by day 10. This dropped to 42% after 21 weeks. Before treatment, most ears (91%) harbored fecal bacteria, Proteus mirabilis (74%) and enterococci (60%) being the most frequently isolated microbes. The second group of frequently cultured bacteria were water bacteria e.g. Pseudomonas species and other non-fermenters (69%), whereas the classical otitis media pathogens were detected only in 15% of ears. Before treatment, 9.7% of strains were resistant to ofloxacin, most (30/35) of which were cultured from ears that were eventually cured. After treatment, fecal and water bacteria were still the most frequently found, with 36% new strains and an overall sensitivity to ofloxacin of 58%. Bacterial resistance did not appear to play an important role in the outcome of treatment. These data rather suggest a very high risk of infection due to poor hygiene conditions. Medical treatment can only have a longer-lasting effect if accompanied by community-based programs that focus on improvement of hygiene. A public health approach is necessary alongside a medical approach for the management of CSOM.
Similar articles
-
Ofloxacin otic solution as treatment of chronic suppurative otitis media and diffuse bacterial otitis externa.J Med Assoc Thai. 1995 Sep;78(9):455-9. J Med Assoc Thai. 1995. PMID: 7561571
-
A double-blind comparative study of ofloxacin otic drops versus neomycin-polymyxin B-hydrocortisone otic drops in the medical treatment of chronic suppurative otitis media.J Laryngol Otol. 1996 Apr;110(4):309-14. doi: 10.1017/s0022215100133523. J Laryngol Otol. 1996. PMID: 8733449 Clinical Trial.
-
Microbiological profile with antibiotic sensitivity pattern of cholesteatomatous chronic suppurative otitis media among children.Int J Pediatr Otorhinolaryngol. 2011 Sep;75(9):1104-8. doi: 10.1016/j.ijporl.2011.05.025. Epub 2011 Jun 28. Int J Pediatr Otorhinolaryngol. 2011. PMID: 21715027
-
Efficacy of ofloxacin and other ototopical preparations for chronic suppurative otitis media in children.Pediatr Infect Dis J. 2001 Jan;20(1):111-5; discussion 120-2. doi: 10.1097/00006454-200101000-00040. Pediatr Infect Dis J. 2001. PMID: 11176589 Review.
-
In vitro and in vivo antimicrobial activity of topical ofloxacin and other ototopical agents.Pediatr Infect Dis J. 2001 Jan;20(1):102-3; discussion 120-2. doi: 10.1097/00006454-200101000-00037. Pediatr Infect Dis J. 2001. PMID: 11176586 Review.
Cited by
-
Chronic suppurative otitis media.BMJ Clin Evid. 2012 Aug 6;2012:0507. BMJ Clin Evid. 2012. PMID: 23870746 Free PMC article.
-
Systemic antibiotics for chronic suppurative otitis media.Cochrane Database Syst Rev. 2021 Feb 4;2(2):CD013052. doi: 10.1002/14651858.CD013052.pub2. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2025 Jun 9;6:CD013052. doi: 10.1002/14651858.CD013052.pub3. PMID: 35819801 Free PMC article. Updated.
-
Topical versus systemic antibiotics for chronic suppurative otitis media.Cochrane Database Syst Rev. 2021 Feb 9;2(2):CD013053. doi: 10.1002/14651858.CD013053.pub2. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2025 Jun 9;6:CD013053. doi: 10.1002/14651858.CD013053.pub3. PMID: 33561891 Free PMC article. Updated.
-
Topical antiseptics for chronic suppurative otitis media.Cochrane Database Syst Rev. 2025 Jun 9;6(6):CD013055. doi: 10.1002/14651858.CD013055.pub3. Cochrane Database Syst Rev. 2025. PMID: 40484403
-
Chronic suppurative otitis media.BMJ Clin Evid. 2007 Feb 1;2007:0507. BMJ Clin Evid. 2007. PMID: 19454051 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources